MedTrace Logo

MISP 60528 Pneumococcal Vaccination

NCT04845945 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 4

Last updated 2026-02-04

No results posted yet for this study

Summary

This study aims to use two different blood tests (ELISA and OPA) to study response to pneumococcal vaccination administered as per standard guidelines in patients who are undergoing workup for heart transplant (whether or not they have undergone LVAD implantation or have undergone heart transplant.

Conditions

  • Heart Transplant Infection Prevention

Interventions

BIOLOGICAL

PCV15

Blood draw after the vaccination

Sponsors & Collaborators

  • Merck Sharp & Dohme LLC

    collaborator INDUSTRY

  • Sunfire Biotechnologies

    collaborator UNKNOWN

  • Quest Clinical Research

    collaborator OTHER

  • Montefiore Medical Center

    lead OTHER

Principal Investigators

  • Vagish Hemmige, MD · Montefiore Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-10
Primary Completion
2024-08-24
Completion
2024-08-24
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04845945 on ClinicalTrials.gov